消除剖宫产术后常规使用阿片类药物的质量改进干预评估
在一家三级医疗中心对剖宫产患者实施质量改进干预,包括取消术后常规口服阿片类药物医嘱、制定必要时的短程阿片类药物医嘱指南、出院处方与住院期间阿片使用模式挂钩并结合共享决策。干预前191例、干预后181例病历回顾及患者调查显示,住院期间使用口服阿片类药物的比例从68%(130例)降至45%(82例),出院带阿片类处方比例从91%降至40%,疼痛评分和满意度无变化。
要点
- 干预后住院期间口服阿片使用比例45%(82例) vs 干预前68%(130例),P<.001。
- 干预后出院带阿片类处方比例40% vs 干预前91%,P<.001。
- 疼痛评分和疼痛缓解总体满意度无变化。
核心结论
- 消除剖宫产术后常规口服阿片类药物医嘱与阿片类药物消耗显著减少相关,同时维持相同的疼痛控制和患者满意度。
- 很大比例的剖宫产术后女性不需要口服阿片类药物。
研究设计与样本
- 在三级医疗中心对教师诊疗组剖宫产患者实施质量改进干预,干预包括取消术后常规口服阿片类药物医嘱、制定必要时的短程阿片类药物医嘱指南、出院阿片类处方与住院期间使用模式挂钩并结合共享决策。
- 干预前后所有患者均使用椎管内阿片类药物,并在无禁忌时给予计划性对乙酰氨基酚和非甾体抗炎药。
- 通过干预前12周和干预后12周的患者病历回顾和患者调查评估干预效果,评估干预前191例和干预后181例剖宫产术后患者记录。
主要发现
- 干预后住院期间使用口服阿片类药物的比例为45%(82例),干预前为68%(130例),P<.001。
- 干预后出院带阿片类处方比例为40%,干预前为91%,P<.001。
- 疼痛评分和疼痛缓解总体满意度无变化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the effects of eliminating the routine use of oral opioids for postcesarean delivery analgesia on postcesarean opioid consumption. METHODS: At a tertiary care center, we implemented a quality improvement intervention among faculty practice patients undergoing cesarean delivery, which consisted of 1) eliminating routine ordering of oral opioids after cesarean delivery, 2) implementing guidelines for ordering a short course of opioids when deemed necessary, and 3) coupling opioid prescribing at discharge to patterns of opioid use in-hospital combined with shared decision-making. All patients, both before and after the intervention, were administered neuraxial opioids and scheduled acetaminophen and nonsteroidal antiinflammatory medications in the absence of contraindications. The primary outcome was the percentage of women who used any opioids postoperatively in-hospital. Secondary outcomes included the percentage of women discharged with a prescription for opioids, the quantity of opioids used in-hospital, pain scores, satisfaction, opioid-related side effects, and opioid prescriptions ordered in the 6 weeks after delivery. The effects of this intervention were assessed based on a chart review of patient data and a survey of patients in the 12 weeks before and 12 weeks after the intervention. RESULTS: We evaluated the records of 191 postcesarean delivery patients before and 181 after the intervention. Less than half of women used oral opioids in-hospital after the intervention, 82 (45%) compared with 130 (68%) before (P<.001). However, there was no change in pain scores or overall satisfaction with pain relief. Postintervention, only 40% of patients were discharged with prescriptions for opioids compared with 91% of patients before the intervention (P<.001). CONCLUSION: Eliminating routine ordering of oral opioids after cesarean delivery is associated with a significant decrease in opioid consumption while maintaining the same levels of pain control and patient satisfaction. Oral opioids are not needed by a large proportion of women after cesarean delivery.
引用
- Holland E, Bateman BT, Cole N, et al. Evaluation of a Quality Improvement Intervention That Eliminated Routine Use of Opioids After Cesarean Delivery. Obstet Gynecol. 2019. PMID: 30531571. doi:10.1097/AOG.0000000000003010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。